Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophils-Reference-Cited by-同舟云学术

Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophils

Published:1995-07 Issue:3 Volume:50 Page:367-380
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Mays Dennis C.,Pawluk Lew J.,Apseloff Glen,Davis W.Bruce,She Zhi-Wu,Sagone Arthur L.,Gerber Nicholas

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference58 articles.

1. Sodium diphenyl hydantoinate in treatment of convulsive disorder;Merritt;J Am Med Assoc,1938

2. Intoxication with 5,5-diphenylhydantoin (Dilantin): Clinical features, blood levels, urinary metabolites and metabolic changes in a child;Holcomb;J Pediatr,1972

3. Antiepileptic Drugs,1982

4. Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue;Martz;J Pharmacol Exp Ther,1977

5. Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins;Pantarotto;Biochem Pharmacol,1982

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Drug Metabolism in Toxicity;Drug Metabolism Handbook;2022-11-18

2. Generation of hydroxyl radical-activatable ratiometric near-infrared bimodal probes for early monitoring of tumor response to therapy;Nature Communications;2021-10-22

3. The many roles of myeloperoxidase: From inflammation and immunity to biomarkers, drug metabolism and drug discovery;Redox Biology;2021-10

4. Phenytoin;The Treatment of Epilepsy;2015-11-17

5. Myeloperoxidase Inhibitors as Potential Drugs;Current Drug Metabolism;2015-08-12